Recombinant SARS-CoV-2 Spike Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD)
| Specifications | |
|---|---|
| Molecular Weight: | ~25 kDa |
| Tag: | His |
| Source: | E.Coli |
| Purity: | >95 % |
| Format: | Liquid |
| Additional Information | |
|---|---|
| Synonyms: | Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD) |
| Organism: | SARS-CoV-2 |
| Accn. No.: | QHD43416 |
Product Citations
- (2021) Suzuki YJ, et al. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vascul Pharmacol, 137 (2021).
- (2020) Bray RA, et al. Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins. Buzhdygan TP, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 146: 105131 (2020).
- (2020) Yu J, et al. Direct activation of the alternative complement pathway by SARS-CoV-2 spike protein is blocked by factor D inhibition. Blood. 2020 Sep 2,blood.2020008248 (2020).
Price
423,00 €
